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African swine fever virus (ASFV) is a highly virulent swine pathogen that has spread across Eastern Europe since
2007 and for which there is no effective vaccine or treatment available. The dynamics of shedding and excretion is
not well known for this currently circulating ASFV strain. Therefore, susceptible pigs were exposed to pigs
intramuscularly infected with the Georgia 2007/1 ASFV strain to measure those dynamics through within- and
between-pen transmission scenarios. Blood, oral, nasal and rectal fluid samples were tested for the presence of
ASFV by virus titration (VT) and quantitative real-time polymerase chain reaction (qPCR). Serum was tested for
the presence of ASFV-specific antibodies. Both intramuscular inoculation and contact transmission resulted in
development of acute disease in all pigs although the experiments indicated that the pathogenesis of the disease
might be different, depending on the route of infection. Infectious ASFV was first isolated in blood among the
inoculated pigs by day 3, and then chronologically among the direct and indirect contact pigs, by day 10 and 13,
respectively. Close to the onset of clinical signs, higher ASFV titres were found in blood compared with nasal and
rectal fluid samples among all pigs. No infectious ASFV was isolated in oral fluid samples although ASFV genome
copies were detected. Only one animal developed antibodies starting after 12 days post-inoculation. The results
provide quantitative data on shedding and excretion of the Georgia 2007/1 ASFV strain among domestic pigs and
suggest a limited potential of this isolate to cause persistent infection.Introduction
African swine fever virus (ASFV) was introduced into
Georgia in 2007 and continues to spread across Eastern
European countries [1-4]. ASFV is a large enveloped DNA
virus, the only member of the Asfarviridae family, genus
Asfivirus [5], that naturally infects domestic and wild
swine. African swine fever (ASF) is characterised by fever,
haemorrhages and high mortality rates resulting in signifi-
cant economic losses in affected areas [1,6]. There is no
effective treatment or vaccine available so disease control
is based on strict quarantine restrictions and stamping
out measures [7]. The main routes reported for ASFV
transmission are direct contact between infectious and* Correspondence: cguinat@rvc.ac.uk
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unless otherwise stated.susceptible domestic pigs and indirect contact through
contaminated pork, people, vehicles, and fomites [1]. In
Eastern Africa, ASFV is also transmitted by ticks but
their epidemiological role in Eastern Europe has never
been reported [1]. There is a risk that ASFV will spread
further throughout Europe [1]. Therefore, it is import-
ant to obtain a better understanding of ASFV shedding
and excretion within domestic pig farms so that trans-
mission parameters can be appropriately estimated and
then used to inform dynamics models of disease spread.
These would allow the potential impact of various con-
trol policies to be assessed.
The incubation period, i.e. the time from infection to
onset of clinical signs, the latent period, i.e. the time from
infection to onset of infectiousness, and the infectious
period, i.e. the time from onset of infectiousness to death
or recovery, are important epidemiological parameters forLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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fectious diseases [8]. They have not been quantified in ex-
perimental studies for the highly virulent Georgia 2007/1
ASFV strain. So far, there is no evidence for change in the
virulence of this ASFV strain and infections continue to
result in the acute form of the disease with no recovered
or long-term carrier domestic pigs reported [1]. Incuba-
tion, latent and infectious periods are dependent on fac-
tors, such as the quantity of virus shedding and the route
of virus excretion, which may in turn depend on the in-
fectious dose and the virus strain [9]. Recent infection
studies, with the Armenia ASFV strain, have focused on
wild boar [10,11]. Following inoculation, the wild boar
developed clinical signs after an incubation period from
3 to 4 days, virus shedding after a latent period from 2
to 6 days and all of them died between 7 and 9 days
post-inoculation (dpi) [10,11]. ASFV-specific antibodies
have been rarely reported in tested serum and organ
samples from domestic pigs and wild boar from affected
areas in Eastern Europe, supporting the view that acute
disease results in death before the development of a
detectable antibody response [1]. Other experimental
infections have mainly studied the susceptibility of do-
mestic pigs to infection with ASFV strains that circulate
in Africa [12-16]. After inoculation with these strains,
domestic pigs generally started to shed virus in blood
after a latent period from 1 to 7 days. Some of them,
infected with lower virulent ASFV strains, became per-
sistently infectious for more than 70 dpi [12]. During
the infectious period, they excreted higher ASFV titres
through the oral route than for the nasal and rectal
routes [12-16].
To our knowledge, no detailed information is available
about the dynamics of virus shedding and excretion of
the ASFV strain that is currently circulating among do-
mestic pigs in Eastern Europe. We therefore investigated
clinical signs, viremia and virus excretion patterns in do-
mestic pigs which became infected by intramuscular in-
oculation and contact transmission with the Georgia
2007/1 ASFV strain in a controlled environment. The im-
plications of these disease parameters for disease detection
and transmission are discussed.
Material and methods
Animals and housing
Forty specific pathogen-free female Large White pigs (Sus
scrofa domesticus) aged 7 weeks, coming from the same
herd in the United Kingdom, were used. Animals were
identified individually and randomly housed in four inde-
pendent isolation rooms (width × length: 385–423 cm×
550 cm) within a containment Level 4 facility at the
Pirbright Institute, Surrey, United Kingdom. Animals were
fed twice a day by the animal caretakers and water was
provided ad libitum. We calculated the minimum numberof pairs of infectious/contact pigs providing high power
(0.95) to detect a significant difference (0.05) in transmis-
sion between a control and treatment group. For this cal-
culation, we considered the probability of infection p in
each group defined as p = R0/(R0 + 2) [17] with R0, the
basic reproduction number, i.e. the average number of
newly infected cases caused by one infectious individual
during its infectious period in a susceptible population
[18]. Based on R0-control = 6.9 [19] and R0-treatment =
0.5, at least 4 pairs of infectious/contact pigs were re-
quired. Calculations were carried out using the R package
“epi.studysize” [20]. Therefore, ten pigs were allocated to
room A. Twelve pigs were allocated to rooms B and C, in
which eight pigs were separated from the other four by an
80 cm high partition, so that between-pen transmission
could be quantified. The sample size was slightly modified
for room D as the number of pigs available and the isola-
tion room size were limited. For these reasons, only six
pigs were allocated to room D. All animal experiments
were carried out under UK Home Office Licence number
70/7198 with the approval of the animal ethics committee
at the Pirbright Institute and complied fully with the regu-
lated procedures from the Animals (Scientific Procedures)
Act 1986.
Virus strains
The highly virulent Georgia 2007/1 ASFV strain was ini-
tially isolated from an infected pig originating from the
Imereti Province in western Georgia in 2007 [21] and is
genetically very close to ASFV strains that currently
circulate in the Trans Caucasian countries and in the
Russian Federation [22,23]. Virus was prepared from in-
fected spleen tissue and the animals were inoculated
with 1 mL of virus at 102 50% hemadsorbing doses
(HAD50). The inoculum of 10
2 HAD50 was chosen as
this amount of virus was previously shown to efficiently
induce infection by the intramuscular route [9].
Experimental infection and transmission
Domestic pigs were inoculated intramuscularly, after a
5-day acclimatisation period. While the intramuscular
route does not represent the natural infection, it appears
to be the most reliable manner of challenge, allowing
high incidence of infection, control of dose and timing
of challenge [9]. The inocula were back-titrated to con-
firm the administered dose. Table 1 shows the number
of inoculated and contact pigs per room. Five out of ten
pigs were infected in room A, four out of twelve pigs
were inoculated in room B, four out of twelve pigs were
inoculated in room C and three out of six pigs were inocu-
lated in room D. The remaining pigs served as within-pen
contact pigs if they were in the same pen as the inoculated
pigs or as between-pen contact pigs if they were in the ad-
jacent pen.
Table 1 Experimental infection and transmission results
with the Georgia 2007/1 ASFV strain
Room A B C D
No. inoculated pigs 5 4 4 3
No. within-pen contact pigs 5 4 4 3
No. between-pen contact pigs 0 4 4 0
No. naturally infected pigs 5 8 8 3
Samples* B, NS, OS, RS, R
*B: Blood, OS: Oral swab, NS: Nasal swab, RS: Rectal swab, R: Rope.
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Pigs were examined daily for clinical signs. To assess the
severity of the disease, a list of ten clinical signs has been
defined and expressed quantitatively using a clinical
score (CS) system [24]. Pigs with a rectal temperature
over 40.5 °C for three consecutive days or showing three
different clinical signs of disease were euthanized in ac-
cordance with the welfare regulations specified in the
UK Home Office Licence under which animal experi-
ments with ASFV are carried out at the Pirbright Insti-
tute. Post-mortem examination was performed for each
pig and collected tissues (tonsil, spleen, kidney, lung,
heart, lymph nodes) were examined for types of macro-
scopic lesions in accordance with the standardized patho-
logical framework of ASFV infections [25].
Sampling procedures
Individual pigs were removed from the room during
sample collection in order to avoid contamination. Small
pigs were restrained in dorsal recumbency and large pigs
remained standing, restrained with a nasal snare. Be-
tween successive samplings, all materials necessary for
blood sampling, clothing, footwear, gloves and floors
were cleaned and disinfected. Blood and serum samples
were collected every two days starting at day 3 post-
inoculation until the end of the experiment. Oral, nasal
and rectal samples were collected daily starting at day 2
post-inoculation using cotton swabs and soaked in 1 mL
PBS. Negative control samples were collected at day 0,
the day of inoculation. Oral swabs were taken between
the cheeks and molar teeth. Fluids were collected from
the cotton swabs after vortexing. Additional oral fluid
was collected daily from a pressed rope hung in each
room which could be chewed by the animals. All sam-
ples were stored at −80 °C until they were analysed by
quantitative real-time polymerase chain reaction (qPCR)
and virus titration (VT).
Quantitative real-time polymerase chain reaction
Samples were analysed by qPCR to determine the quan-
tity of ASFV genome copies, according to the procedure
described in King et al. [26] with slight modifications.
The DNA was extracted with the QIAamp® All NucleicAcid Kit MDx Kit (Qiagen, UK) using an automated
Qiagen Universal BioRobot (Qiagen, UK). After the DNA
extraction procedure, the cartridge was processed for the
qPCR. The target for amplification of the ASFV genome
was the conserved p72 gene segment, using the following
primers: 5′-CTG CTC ATG GTA TCA ATC TTA TCG
A-3′ and 5′-GAT ACC ACA AGA TC(AG) GCC GT-3′.
Analysis was performed using the MxPro software and the
qPCR procedure included the following step: denatur-
ation (95 °C), annealing (58 °C) and elongation (72 °C).
The quantity of ASFV genome was calculated using the
standard curve and expressed as genome copies per
millilitre (/mL).
Virus titration
Samples were analysed by VT to determine the quantity
of infectious ASFV. Primary porcine bone marrow cells
were incubated in 96-well plates at 37 °C in an atmosphere
with 5% CO2. After 3 days, the medium was discarded
and fresh medium (Eagle minimum essential medium
(EMEM) with 10% of pig serum, 1:250 of HEPES and 2%
of antibiotics solution (Penicillin, Streptomycin, Ampho-
tericin, Kanamycin)) was added to the wells. Samples were
added to the plates and titrated in triplicate using dilutions
ranging from 10-1 to 10-8. After 3 days, the quantity of
ASFV was determined by identification of characteristic
rosette formation representing hemadsorption of erythro-
cytes around infected cells. ASFV titres were expressed as
doses per millilitre (HAD50/mL) calculated using the
Spearman-Karber method [27].
Detection of ASFV-specific antibodies
Serum samples were tested for ASFV-specific antibodies
with the Ingezim PPA Compac kit (Ingenasa, Madrid,
Spain), according to the manufacturer’s instructions.
This detects levels of antibodies against the VP72 (or
VP73 capsid protein). Negative and positive cut-off
values were calculated to interpret the results.
Statistical analysis
For all clinical signs and viral patterns recorded, the
mean ± standard deviation was calculated for the three
groups, inoculated, within- and between-pen contact
pigs, using data for individual pigs obtained daily. For
the inoculated pigs, we calculated the average duration
of the latent and the incubation period. Since data on
the day of infection were not available for the contact
pigs, the average duration between the exposure and the
onset of infectiousness or clinical signs were calculated.
For all animals, we calculated the average duration of
the infectious period although all pigs were euthanized
for animal welfare reasons. The average duration of each
of the different time periods was compared between
groups using a one-way ANOVA test. The onset of clinical
Table 2 Results of the average duration of latent and
incubation period for the inoculated pigs and time
to onset of infectiousness and clinical signs for the
contact pigs
Inoculated pigs Within-pen
contact pigs
Between-pen
contact pigs
Samples Latent period* Time to onset of
infectiousness†
Blood ‡ 4.8 (± 1.3) 10.3 (± 1.6) 13.9 (± 3.0)
Blood § 3.6 (± 1.0) 10.4 (± 1.4) 13.1 (± 3.0)
Oral swab ‡ 5.4 (± 1.3) 8.5 (± 1.5) 9.2 (± 1.5)
Nasal swab ‡ 5.4 (± 1.4) 7.6 (± 2.6) 11.3 (± 0.5)
Rectal swab ‡ 4.9 (± 1.4) 9.3 (± 2.9) 11.0 (± 1.6)
Incubation period* Time to onset of clinical signs†
Clinical score >3 4.4 (± 1.0) 9.9 (± 1.6) 12.7 (± 2.0)
*Average number of days post inoculation (± standard deviation).
†Average number of days post exposure (± standard deviation).
‡Results by quantitative real-time polymerase chain reaction.
§Results by virus titration.
Figure 1 Macroscopic lesions observed in organs of domestic pigs infected with the Georgia 2007/1 ASFV strain. A) Enlarged and
haemorrhagic hepatogastric lymph node from a between-pen contact pig terminated at 11 days post exposure. B) Multifocal cortical
haemorrhages (petechiae) on kidney from an inoculated pig terminated at 8 days post-inoculation. C) Fluid in pericardial cavity (hydropericardium)
from a within-pen contact pig terminated at 12 days post-exposure.
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a t-test. The type of post-mortem lesions were compared
between groups using a one-way ANOVA test. The values
of clinical scores and viral shedding were compared
between groups in relation to time using a linear mixed ef-
fect model. All statistical analyses and plots were per-
formed using the R statistical program [20]. The packages
“epi.studysize”, “lme4”, “lmerTest”, “latticeExtra” and p <
0.05 were used to indicate statistical significance.
Results
Inoculation and transmission
All study pigs were susceptible to the Georgia 2007/1
ASFV strain resulting in infection of all animals as a re-
sult of intramuscular inoculation or contact transmission
(Table 1). One inoculated pig survived until day 12 post-
inoculation, but all other inoculated pigs were eutha-
nized by day 9. All within- and between-pen contact pigs
were euthanized by day 14 and day 18 post-exposure,
respectively.
Macroscopic lesions
Figure 1 shows the most common macroscopic lesions ob-
served for the three groups of pigs at post-mortem exam-
ination. There was no significant difference in the type of
lesions among the three groups. We observed enlarged
and haemorrhagic lymph nodes (submandibular, mesen-
teric, tracheo-bronchial and hepatogastric), enlarged and
haemorrhagic spleen, multifocal cortical haemorrhages
(petechiae) on lung, kidney and liver, and accumulation of
fluid in the pericardial cavity (hydropericardium).
Clinical signs and incubation period
Most pigs showed fever (higher than 40 °C for more
than two consecutive days), loss of appetite, lethargy and
dysentery. Table 2 shows the average duration of the in-
cubation period for the inoculated pigs and the time to
onset of clinical signs for the contact pigs. There was a
significant difference in time to the appearance of clin-
ical signs among the three groups. The inoculated pigs
first started to show clinical signs at 4.4 ± 1.0 dpi,followed chronologically by the within- and the between-
pen contact pigs, at 9.9 ± 1.6 and 12.7 ± 2.0 days post-
exposure (dpe), respectively. The increase in clinical scores
per day was significantly different between groups and
tended to be higher for the inoculated pigs than for the
within- and between-pen contact pigs, i.e. 0.5 ± 0.1/day
and 0.3 ± 0.1/day respectively (Figure 2G).
Latent period and time to onset of infectiousness
Table 2 shows the average duration of the latent period
for the inoculated pigs and the time to onset of infectious-
ness for the contact pigs, by ASFV genome or infectious
ASFV detection in blood, oral, nasal and rectal samples.
There was a significant difference in time to the appear-
ance of infectious ASFV in blood among the three groups.
The appearance of ASFV genome in blood among the
three groups was not significantly different from infectious
ASFV. In the inoculated pigs, infectious ASFV was first
isolated in the blood at 3.6 ± 1.0 dpi, and generally two
days later in the swabs. In the within-pen contact pigs, in-
fectious ASFV was isolated in the blood at 10.4 ± 1.4 dpe,
Figure 2 Results of clinical signs, viremia and virus excretion patterns observed in domestic pigs infected intramuscularly (solid line
type) with the Georgia 2007/1 ASFV strain, by direct contact (dashed line type) or by indirect contact (dotted line type). A) ASFV titres
in blood. B) ASF genome copies in blood. C) ASFV titres in nasal fluid. D) ASF genome copies in nasal fluid. E) ASFV titres in rectal fluid. F) ASF
genome copies in rectal fluid. G) Clinical score. H) ASF genome copies in oral fluid. Means and standard deviations per time (days) are shown for
all inoculated, within- and between-pen contact pigs.
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days before. In the between-pen contact pigs, infectious
ASFV was isolated in the blood at 13.1 ± 3.0 dpe, although
ASFV genome could be also detected earlier in swabs.
Considering the standard deviation, values for the time to
onset of viremia tended to spread over a larger rangewithin the contact pigs than within the inoculated pigs.
The time to onset of infectious ASFV in blood and clinical
signs were not significantly different among the contact
pigs while the difference was significant for the inoculated
pigs. Infectious ASFV was occasionally isolated in nasal
and rectal swabs among the three groups while oral swabs
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from the ropes indicated the presence of ASFV genome
from day 5 in the room A and from day 13 in the room C
but no infectious ASFV was recovered from these sam-
ples. No ASFV-specific antibodies were detected except
from one inoculated pig at 12 dpi.Detection of ASFV genome and infectious ASFV
Figure 2 shows the average values of infectious ASFV
and ASFV genome detected in blood, oral, nasal and rec-
tal swabs and the clinical signs for the three groups of
pigs. Highest ASFV titres were mainly found in blood
ranging from 106 to 108 HAD50/mL (Figure 2A) and small
amounts were occasionally detected in nasal and rectal
swabs ranging from 102 to 104 HAD50/mL (Figure 2C and
2E). The increase of the ASFV titres in blood per day was
significantly different between groups and tended to be
higher for the inoculated pigs than for the within- and
between-pen contact pigs, 0.5 ± 0.1 log10 HAD50/mL/day
compared to 0.3 ± 0.1 log10 HAD50/mL/day, respectively.
Considering the standard deviation, larger range of ASFV
titres in blood were observed within the contact pigs than
for the inoculated pigs (Figure 2A). Infectious ASFV was
occasionally isolated in nasal and rectal fluid samples al-
though high ASFV genome copies values were detected
(Figure 2D and 2F). No infectious ASFV was isolated in
oral fluid samples although ASFV genome copies were de-
tected (Figure 2H).Infectious period
Table 3 shows the average duration of the infectious
period for each of the three groups of pigs by ASFV gen-
ome and infectious ASFV detection in blood, oral, nasal
and rectal samples. There was a significant difference in
the duration of the infectious period among the three
groups. ASFV genome and infectious ASFV were detected
within blood from the inoculated pigs for a significantly
longer time compared to the contact pigs. In addition,
ASFV genome and infectious ASFV were detected in oral,Table 3 Results of the average duration of infectious
period
Inoculated pigs Within-pen
contact pigs
Between-pen
contact pigs
Samples Infectious period*
Blood † 3.5 (± 1.3) 2.4 (± 1.2) 2.3 (± 0.9)
Blood ‡ 4.7 (± 1.4) 2.4 (± 0.7) 3.0 (± 1.2)
Oral swab † 3.2 (± 1.2) 4.8 (± 1.5) 7.7 (± 3.3)
Nasal swab † 2.9 (± 1.3) 5.0 (± 2.3) 5.4 (± 1.4)
Rectal swab † 3.4 (± 1.2) 3.8 (± 2.3) 5.7 (± 1.7)
*Average number of days (± standard deviation).
†Results by quantitative real-time polymerase chain reaction.
‡Results by virus titration.nasal and rectal swabs among the inoculated pigs for a sig-
nificantly shorter time compared to the contact pigs.
Discussion
The objective of the current study was to provide quan-
titative information on the dynamics of shedding and
excretion of the Georgia 2007/1 ASFV strain among do-
mestic pigs. Results confirmed that pigs are highly suscep-
tible to direct and indirect infection with the currently
circulating ASFV strain in Eastern Europe resulting in de-
velopment of the acute disease form. While one inocu-
lated pig survived until day 12, all others were euthanized
by day 9. All within- and between-pen contact pigs were
euthanized by day 14 and 18, respectively. This work sug-
gests that the Georgia 2007/1 ASFV strain has limited
potential in controlled environment to cause persistent
ASFV infection or result in ASFV carriers in a pig popula-
tion as was also suggested for the wild boar [11]. The in-
fection caused moderate and non-specific clinical signs
and lesions among all pigs [25]. In recent publications,
similar clinical signs and macroscopic lesions were ob-
served in wild boar and domestic pigs during infection ex-
periments using a similar ASFV strain [10,11] and during
ASF outbreaks in domestic pigs in the affected geograph-
ical areas [1,6]. The inoculated pigs generally started to
show clinical symptoms after 3 days post-inoculation,
meaning that significant delay could be possible between
infection and disease reporting within pig farms. These
clinical signs and lesions can be misdiagnosed with other
haemorrhagic diseases such as classical swine fever and
porcine dermatitis and nephropathy syndrome resulting
not only in potential underreporting but also in major
delay for ASFV diagnosis [28,29]. Therefore, ASFV could
spread rapidly through transport of animals between farms,
markets and slaughter houses, without farmers suspecting
and reporting ASFV infection.
This study also shows that the disease transmission is
likely to occur by contact with blood, as was suggested
for wild boar [11]. The average duration of the latent
period/onset of infectiousness was 3.6 ± 1.0, 10.4 ± 1.4
and 13.1 ± 3.0 days for the inoculated, within- and
between-pen contact pigs respectively, according to the
blood samples. The between-pen contact pigs became
viremic significantly later than the within-pen contact
pigs, indicating that specific farm contact infrastructures,
such as fenced premises, could delay the disease transmis-
sion. The three groups showed high ASFV titres in blood
compared to swabs reaching from 106 to 108 HAD50/mL.
Recent studies on domestic pig behaviour reported that
common social interactions, such as feeding or mating,
generally cause skin injuries and if this induces any bleed-
ing then this appears to give rise to more bites and licking
[30]. Therefore, blood would easily contaminate the envir-
onment, especially in a within-pen transmission scenario.
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comparable to the number of ASFV genome copies de-
tected by qPCR, highlighting the utility of this assay in dis-
ease control. However, for a few blood samples from the
inoculated pigs, the latent period was estimated to be
shorter, when tested by virus titration compared to qPCR.
The reasons for these discrepant results are unknown,
however out of the 222 blood samples tested for the pres-
ence of ASFV genome using the OIE qPCR assay [26],
eight samples were misdiagnosed, remaining consistent
with the sensitivity of this assay [31-34]. There was no
significant difference in time to the onset of viremia and
clinical signs in the contact pigs, indicating that natural
transmission mostly occurs at the same time as the ASF
disease signs appear. This last observation emphasizes that
early detection based on clinical signs would not be an ef-
ficient approach for in-farm control for this ASFV strain
in contrast to other infectious diseases where such mea-
sures led to the successful eradication [35].
Moreover, these experiments show that the disease
transmission is also possible through oral, nasal and rec-
tal fluids. These excretions could be easily spread in the
environment by the natural explorative behaviour of do-
mestic pigs resulting in a high chance for ASFV to trans-
mit, especially in a between-pen transmission scenario
[30]. The onset of infectiousness was detected through
the nasal or oral route for the within- and between-pen
contact pigs before these animals showed viremia. How-
ever, infectious ASFV was excreted at lower levels via
these routes compared to blood, reaching from 102 to
104 HAD50/mL. Besides, ASFV isolation in nasal and
rectal swabs rarely produced positive results. Inconsistent
with reports from other studies [10-12], no ASFV was iso-
lated in oral swabs or from ropes samples. This suggests
that either ASFV survival may be reduced through the oral
route by potential presence of inhibitors in saliva or that
ASFV in samples was rapidly inactivated and unsuitable
for detection by virus titration, although false positive re-
sults due to contamination in the qPCR assay cannot be
excluded [36]. ASFV genome was generally detected in
oral and nasal samples from the contact pigs before they
developed viremia. This could be explained by the fact
that ASFV appears to first replicate in monocytes and
macrophage cells from lymph nodes close to the initial
site of infection [37]. Hence, ASFV would first replicate in
the oropharyngeal region when pigs are infected by con-
tact transmission resulting in excretion of infectious virus
through the oral and nasal routes prior to systemic dis-
semination. This also indicates that detection of ASFV
genome in oronasal swabs would be a relevant tool for
early diagnosis of infected pigs as it has been suggested for
CSFV [38].
Several factors from the experiments demonstrate that
the pathogenesis of the disease might be different,depending on the route of infection. For the inoculated
pigs, the first detection of ASFV genome was in blood
while it was in oral and nasal swabs for the contact pigs,
suggesting earlier systemic spread with the intramuscu-
lar inoculation. Moreover, the increase of the ASFV ti-
tres in blood per day was significantly different between
the three groups and tended to be higher for the inocu-
lated pigs, suggesting a faster disease progression with
the intramuscular inoculation. Similar results were re-
ported for the increase of the clinical scores although
the type of clinical signs did not vary according to the
route of infection. Also smaller standard deviations in
infection and shedding patterns were observed among
the inoculated pigs, suggesting reduced natural heterogen-
eity with the intramuscular inoculation. Finally, there was
a significant difference in the duration of the infectious
period among the three groups although all the animals
were euthanized before their natural death. This variation
in pathogenesis may be due to different primary sites of
replication for the intramuscular and natural infection
routes, affecting the dynamics of ASFV shedding and ex-
cretion [9,37]. Consequently, data from the inoculated
pigs could not be considered as representative of the
natural course of ASFV infection as data from the contact
pigs. These observations stress that further effort is
needed to obtain more accurate information on the course
of ASFV infection. Although probably less effective than
the intramuscular route, other inoculation routes could be
considered [9] but also additional transmission experi-
ments with the use of secondary contact infection [39] or
modelling approaches [8]. All pigs were euthanized before
their death caused by the disease for animal welfare rea-
sons, resulting in possible bias for the infectious period
duration estimations. However, domestic pigs were previ-
ously reported to generally be infectious for similar time
intervals, i.e. from 3 to 6 days [11]. Finally, serology results
showed that ASFV-specific antibodies were detected in
only one inoculated pig at 12 dpi. Previous studies have
described the important role of antibody detection in the
control of the disease for low virulence ASFV strains [40].
In the affected areas in Eastern Europe, animals have only
been reported to develop the acute form of the disease so
far and mostly died at a very early stage of the disease,
before the appearance of ASFV specific antibodies [1].
Therefore, our results may imply that serology does not
provide a reliable method for disease surveillance in the
context of the current circulating ASFV strain unless the
virulence of ASFV strains reduces such that longer term
or persistent infections could occur.
Results should be considered carefully as many factors,
including virus shedding, exposure time, virus survival,
sample size and others experimental conditions may in-
fluence the outcome of the transmission studies. As an
example, variability was observed in ASFV shedding or
Guinat et al. Veterinary Research 2014, 45:93 Page 8 of 9
http://www.veterinaryresearch.org/content/45/1/93time to onset of infectiousness within the contact pigs.
This could be explained by individual susceptibility to
infection or specific type of contacts between infectious
and susceptible pigs that would determine transmission
efficiency. However, this experimental study proved to
have the main advantages of requiring a limited number
of animals, allowing frequent animals sampling and en-
vironmental factors control compared to field studies. In
all experiments, ASFV transmission occurred, suggesting
that the disease could spread easily among domestic pigs
within pig farms. However, field observations indicated
that during ASF outbreaks, the pig mortality rate could
be low and that despite the high virulence of the Georgia
2007/1 ASFV strain, healthy susceptible pigs were re-
ported within infected herds [41]. This also implies that
disease transmission may occur at different rates prob-
ably as a result of host characteristics or animal hus-
bandry [18,42,43]. In conclusion, these results provide
the first quantitative information to be used for estimat-
ing transmission parameters for ASFV and thus develop-
ing future dynamic transmission models of within-herd
ASFV spread. This will have potential applications for
the development and implementation of transmission
control policies.
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